 REDWOOD CITY, Calif., Dec. 29, 2021 GLOBE NEWSWIRE -- Pulmonx Corporation Nasdaq: LUNG Pulmonx a global leader in minimally invasive treatments for severe lung disease, today announced the company will present at the upcoming 40th Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Tuesday, January 11, 2022, at 7:30 a.m. Eastern Standard Time. 